IREN · IREN Limited

This $2 billion convertible notes offering represents a significant financing event for IREN, materially altering its debt profile and equity-dilution dynamics. The notes are senior unsecured obligations maturing in 2033, with interest rate, conversion rate, and cap price all undetermined pending pricing — introducing execution risk and uncertainty around effective cost of capital and dilution impact. The inclusion of a $300 million greenshoe option signals strong anticipated demand but also increases potential dilution exposure if exercised. Critically, IREN’s planned capped call transactions are structured to limit dilution and offset cash settlement obligations upon conversion, yet the press release explicitly acknowledges that dilution and uncapped cash payments remain possible if IREN’s share price exceeds the cap price — a key risk for existing shareholders. The redemption feature beginning in 2030 ties issuer call rights to sustained stock performance (130% of conversion price), creating potential pressure on equity valuation and signaling management’s confidence in long-term share appreciation. As an unregistered Rule 144A offering, the notes lack public market liquidity and regulatory disclosures applicable to registered securities, restricting participation to sophisticated investors and reducing transparency. Proceeds allocation prioritizes hedging mechanics (capped calls) over strategic capital deployment — suggesting near-term financial engineering focus rather than direct growth investment. Given the size relative to IREN’s scale, maturity profile, and structural complexity, this transaction carries high implications for leverage, earnings per share, share count, and investor sentiment.